Amira Abdel Moneam Adly
Overview
Explore the profile of Amira Abdel Moneam Adly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adly A, Rahman Ismail E, A Ibrahim F, Atef M, El Sayed K, Aly N
J Inherit Metab Dis
. 2024 Aug;
48(1):e12792.
PMID: 39183538
Enzymatic deficiency in Gaucher disease (GD) may induce oxidative stress. Vitamin E is the nature's most effective lipid-soluble antioxidant. This prospective clinical trial assessed the oxidant-antioxidant status in Egyptian patients...
2.
Tantawy A, Tadros M, Adly A, Rahman Ismail E, A Ibrahim F, Salah Eldin N, et al.
Cytokine
. 2022 Oct;
161:156048.
PMID: 36279697
Background: Endothelin-1 (ET-1), a potent endogenous vasoconstrictor, stimulates production of reactive oxygen species. Endothelial monocyte-activating polypeptide-II (EMAP-II) is a multifunctional polypeptide. Aim: To assess ET-1 gene polymorphism (G8002A) in pediatric...
3.
Tantawy A, Adly A, Atif H, Madkour S, Salah N
Pediatr Hematol Oncol
. 2021 Oct;
39(4):304-317.
PMID: 34668825
Few case reports and series reported abdominal lymphadenopathy (ALN) in people with Gaucher disease (GD). However, it's prevalence among Gaucher population, clinical implications and potential biomarkers are unknown. Hence this...
4.
Ganglion Cell Complex Thinning in Young Gaucher Patients: Relation to Prodromal Parkinsonian Markers
Tantawy A, Adly A, Hashem N, Ebeid W, Abdeen M, Salah N
Mov Disord
. 2020 Sep;
35(12):2211-2219.
PMID: 32918500
Background: Patients with Gaucher disease (GD) have an increased risk for parkinsonism. Retinal thinning has been described in parkinsonism as an early nonmotor feature. Scarce reports have addressed retinal thickness...
5.
Tantawy A, Adly A, Abdeen M, Salah N
Neurogenetics
. 2020 Mar;
21(3):159-167.
PMID: 32215803
Evidence about the link between glucocerebrosidase (GCase) and parkinsonism is growing. Parkinsonism was described in adult type 1 Gaucher disease (GD); few case reports described it in type 3GD. To...
6.
Tantawy A, Adly A, Madkour S, El-Din N
Pediatr Pulmonol
. 2019 Nov;
55(2):441-448.
PMID: 31774256
Background: Although pulmonary involvement is important orbidity in Gaucher disease (GD), it is previously reported to be rare. Moreover, no epidemiological studies described its prevalence specifically in children. The clinical...
7.
Tantawy A, Adly A, El-Din N, Abdeen M
J Psychosom Res
. 2019 May;
122:75-81.
PMID: 31079842
Objectives: Gaucher disease (GD) may include psychiatric symptoms as a part of its wide spectrum of manifestations, with several reports describing its association with mood or psychotic symptoms. We investigated...
8.
Elalfy M, Adly A, Ebeid F, Eissa D, Rahman Ismail E, Mohammed Y, et al.
Immunol Res
. 2018 Jun;
66(4):480-490.
PMID: 29926339
Sickle cell disease (SCD) is associated with alterations in immune phenotypes. CD4CD28 T lymphocytes have pro-inflammatory functions and are linked to vascular diseases. To assess the percentage of CD4CD28 T...
9.
Tantawy A, Adly A, Rahman Ismail E, Youssef O, Ali M
Clin Appl Thromb Hemost
. 2017 Mar;
23(8):943-950.
PMID: 28301910
Endothelial damage has been implicated in the pathogenesis of vascular complications in β-thalassemia intermedia (β-TI). Soluble fms-like tyrosine kinase 1 (sFLT-1) is a member of the vascular endothelial growth factor...
10.
Adly A, Elsherif N, Rahman Ismail E, Ibrahim Y, Niazi G, Elmetwally S
Redox Rep
. 2017 Mar;
22(6):430-438.
PMID: 28288539
Background: Ischemia-modified albumin (IMA) is an altered type of serum albumin that forms under conditions of oxidative stress and an independent predictor of major adverse cardiovascular events. Objectives: To measure...